The differential anti-tumor activity of these IFN-inducible chemokines appears to depend on the penultimate amino acid sequence of the NH2-terminus of the chemokine peptide chain that is cleaved by DPP4/CD26 [34,35], which is expressed in the tumor stromal tissue. Here, DPP4 is linked to neoplasm.